Who owns the ACROPIEL trademark?

The ACROPIEL trademark is owned by HYUNDAI PHARM CO., LTD..

What class is the ACROPIEL trademark registered in?

The ACROPIEL trademark is registered in Class 035 (Advertising, business management & retail services).

What is the serial number for ACROPIEL?

The USPTO serial number for ACROPIEL is 90372250.

What is the registration number for ACROPIEL?

ACROPIEL is registered under USPTO registration number 7039414.

Sealvo

Home Search: ACROPIELACROPIEL #90372250

Back

Updated Oct 19, 2026·27 searches this week

View on USPTO TSDR Find similar marks

ACR

USPTO Trademark Record

REGISTERED

ACROPIEL

SN 90372250·Reg 7039414·Filed Dec 10, 2020

Owner HYUNDAI PHARM CO., LTD.

Advertising; business management, organization and administration; office functions.

ACROPIEL (Serial No. 90372250), Registration No. 7039414, is a registered US trademark filed on Dec 10, 2020 by HYUNDAI PHARM CO., LTD.. This trademark covers Class 035 (Advertising, business management & retail services).

early section 8: May 02, 2029

Mark Intelligence

ACROPIEL (Reg. #7039414) is a registered US trademark that has been protecting its owner, HYUNDAI PHARM CO., LTD., since 2020. The mark covers Class 035 (Advertising, business management & retail services). Goods and services include Advertising; business management, organization and administration; office functions.. The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 10, 2020

SERIAL

90372250

REG#

7039414

REGISTERED

May 02, 2023

Filing Information

StatusREGISTERED

Filing DateDec 10, 2020

Serial Number90372250

Registration No.7039414

Registration DateMay 02, 2023

Status DateMay 02, 2023

Published for OppositionFeb 14, 2023

Filing Basis & Declarations

Standard Characters Claimed

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 035Advertising, business management & retail services

US codes: 100, 101, 102

Advertising; business management, organization and administration; office functions.

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

23 events

REGISTERED-PRINCIPAL REGISTER

May 02, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 02, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Feb 14, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 14, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 25, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 08, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 05, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 05, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Dec 31, 2022

ASSIGNED TO LIE

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Nov 04, 2022

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Aug 08, 2022

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

SUSPENSION LETTER WRITTEN

Feb 07, 2022

SUSPENSION LETTER WRITTEN

LETTER OF SUSPENSION E-MAILED

Feb 07, 2022

LETTER OF SUSPENSION E-MAILED

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Feb 07, 2022

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 19, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 18, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 18, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

May 29, 2021

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

May 29, 2021

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 29, 2021

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

May 28, 2021

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 17, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Dec 14, 2020

NEW APPLICATION ENTERED

Other Marks by HYUNDAI PHARM CO., LTD.

Additional USPTO filings from the same owner.

CRE

CRESTELLA

98782840

HYUNDAI PHARM. CO., LTD.

REGISTERED

LAP

LAPCLE

99288574

HYUNDAI PHARM. CO., LTD.

REGISTERED

ELC

ELCBALABCLE

97726474

HYUNDAI PHARM CO., LTD.

REGISTERED

ELC

ELCBALABCLE

97726532

HYUNDAI PHARM CO., LTD.

REGISTERED

Other Marks by Corey K. Cho

Additional USPTO filings handled by the same attorney of record.

TAK

TAKECHARGE

85984246

REGISTERED

ATL

ATLASBX

86517915

REGISTERED

FIV

FIVE HEARTS UNDER ONE ROOF

99826814

REGISTERED

TAN

TANGLE

99266424

REGISTERED

ACROPIEL

Run a conflict check

Other Marks by HYUNDAI PHARM CO., LTD.

Other Marks by Corey K. Cho

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company